HOME >> BIOLOGY >> NEWS
Moderate alcohol consumption may reduce your chances of a heart attack

  • 1 of every 2 men and 1 of every 3 women age 40 or less will develop coronary heart disease (CHD).

  • CHD is the number one killer of both men and women in the U.S.

  • High levels of a clotting protein called fibrinogen may contribute to CHD.

  • Moderate alcohol consumption may decrease fibrinogen levels, thereby decreasing harmful clotting.

Heart disease is the number one killer of Americans, according to the National Heart, Lung and Blood Institute of the National Institutes of Health. The most common form of heart disease is coronary heart disease (CHD), which occurs when the coronary arteries become narrowed or clogged and cannot supply enough oxygen-rich blood to the heart. High amounts of a clotting protein called fibrinogen - levels of which tend to increase as people grow older - are associated with coronary artery, cerebral vascular and peripheral vascular diseases. However, a recent study published in the December issue of Alcoholism: Clinical & Experimental Research shows that moderate consumption of alcohol may decrease production and circulating levels of fibrinogen by up to 20 percent.

"This is a very significant finding," said Gerald M. Fuller, senior study author and professor of cell biology at the University of Alabama at Birmingham. "Anything that we can take naturally that reduces high circulating levels of fibrinogen by 15 to 20 percent could have a big impact in terms of coronary artery diseases." He added that "epidemiological studies have overwhelmingly demonstrated the importance of fibrinogen as a risk factor, and diminishing it by a small amount can have a truly profound effect."

Researchers studied the impact of daily consumption of moderate amounts of alcohol - equivalent to roughly two drinks per day - at two levels: using an animal model (in vivo) and liver-derived cells (in vitro). The animal-study findings demonstrated an 18 to 20 percent decrease in the circulatin
'"/>

Contact: Gerald M. Fuller, Ph.D.
gmfuller@cellbio.bhs.uab.edu
205-934-7596
Alcoholism: Clinical & Experimental Research
13-Dec-1999


Page: 1 2 3

Related biology news :

1. Moderate alcohol consumption increases plasma levels of a protective hormone
2. Moderate iron deficiency affects cognitive performance - but iron supplementation improves it
3. Moderate alcohol consumption after meals can decrease levels of insulin
4. Moderate alcohol consumption during pregnancy is risky too
5. Moderate vitamin E supplementation may lower diabetics cardiovascular risk
6. Moderate alcohol consumption increases bone mineral density in elderly women
7. Moderate caffeine use does not increase miscarriage risk but high caffeine use doubles risk
8. Duke Researchers Finds That Moderate Caffeine Use Boosts Blood Pressure, Potential For Heart Disease
9. Even Moderate Air Pollution Reaching Eastern Wilderness Decreases Mountain Hikers Lung Function
10. No Such Luck: Nitrogen From Air Pollution Unlikely to Moderate Global Warming
11. A liking for sweets, combined with novelty seeking, may predict alcoholism

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Moderate alcohol consumption may reduce your chances heart attack

(Date:7/13/2015)... SAN JOSE, Calif. , July 13, 2015 ... the leading developer of human interface solutions, today ... second generation touch and display driver integration (TDDI) ... solution is the first to combine Synaptics , ... expertise with proven display driver technology developed in ...
(Date:7/9/2015)... 2015 Research and ... the "Biometrics for Banking; Market & Technology ... to their offering. The adoption for ... growth and the forecast is that by 2020 ... companies involved in delivering biometric systems to the ...
(Date:7/8/2015)... 2015 Summary Pancreatic cancer is the ... fatal, with a mortality rate of 10.9 deaths per ... cancer patients has highlighted a significant need for new ... met by the current market. A highly active ... varying molecule types and mechanisms of action, which provides ...
Breaking Biology News(10 mins):Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3
(Date:7/29/2015)... July 29, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ... Company,s Chief Financial Officer has resigned.  The Company has ... Officer who retired in December 2014, as full time ... permanent successor.     Andy Ashworth began ... ensure a smooth transition.  Andy was the Company,s CFO ...
(Date:7/29/2015)... 2015 Research and ... of the "Global Biosimilars Market, 2015 - ... The Global Biosimilars Market, 2015 - 2025, report ... biosimilars market. With the blockbuster biologics losing patent ... biosimilars are being viewed as viable substitutes to ...
(Date:7/29/2015)... July 29, 2015  Pfenex Inc. (NYSE MKT: PFNX) ... will be released on Thursday, August 13, 2015, before ... Pfenex management will host a conference call to discuss ... press release outlining the financial results and business update ... Please call 1-866-376-8058 (US) or 1-412-542-4131 (international) and ...
(Date:7/29/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS ... an optimized Erk inhibitor molecule for development, thus ... a new class of potential cancer therapies. ... target for therapeutic intervention in cancer. Recently approved ... for B-Raf and Mek inhibitors. Erk inhibitors may ...
Breaking Biology Technology:BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3
Cached News: